Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19

Published: 4 June 2021| Version 1 | DOI: 10.17632/7fnt3nfhdv.1
yamile lopez


The data contain all the baseline information about participants in the study (COVID-19 patients and non-COVID-19) as well as metabolite measurements made by targeted metabolomics (raw data COVID-19_SR). We also provide the concentration data for metabolites expressed as mean (SD) or median (IQR).